Get informed when a big investor buys or sells
+ FollowOvervalued by 81.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $7.04 Million |
|---|---|
| Enterprise Value | $7.27 Million |
| Earnings per Share | $-5.12 |
| Beta | 3.05 |
| Outstanding Shares | 4,484,133 |
| P/E Ratio | -0.47 |
|---|---|
| PEG | -0.25 |
| Price to Sales | - |
| Price to Book Ratio | 0.31 |
| Enterprise Value to Revenue | 8.44 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.04 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 1.61% |
|---|---|
| Total Invested | $9,621▼ 88.55% |
| Investors Holding | 5▼ 7.00% |
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implant...